1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-781. PMID:
20116997
4. Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, et al. Prostate Cancer Working Group report. Jpn J Clin Oncol 2010;40 Suppl 1:i70-i75.
5. Zhang J, Dhakal IB, Zhao Z, Li L. Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition. Eur J Cancer Prev 2012;21:480-489. PMID:
22357483
10. Van Dong H, Lee AH, Nga NH, Quang N, Le Chuyen V, Binns CW. Epidemiology and prevention of prostate cancer in Vietnam. Asian Pac J Cancer Prev 2014;15:9747-9751. PMID:
25520098
11. Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO. Cigarette smoking and prostate cancer risk: negative results of the Seoul Male Cancer Cohort Study. Asian Pac J Cancer Prev 2013;14:4667-4669. PMID:
24083722
12. Middleton Fillmore K, Chikritzhs T, Stockwell T, Bostrom A, Pascal R. Alcohol use and prostate cancer: a meta-analysis. Mol Nutr Food Res 2009;53:240-255. PMID:
19156715
13. Young-McCaughan S. Potential for prostate cancer prevention through physical activity. World J Urol 2012;30:167-179. PMID:
22198724
15. Wolk A. Diet, lifestyle and risk of prostate cancer. Acta Oncol 2005;44:277-281. PMID:
16076700
16. Xu H, Mao SH, Ding GX, Ding Q, Jiang HW. Diabetes mellitus reduces prostate cancer risk - no function of age at diagnosis or duration of disease. Asian Pac J Cancer Prev 2013;14:441-447. PMID:
23534770
17. Bansal D, Bhansali A, Kapil G, Undela K, Tiwari P. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis 2013;16:151-158. PMID:
23032360
18. Long XJ, Lin S, Sun YN, Zheng ZF. Diabetes mellitus and prostate cancer risk in Asian countries: a meta-analysis. Asian Pac J Cancer Prev 2012;13:4097-4100. PMID:
23098523
19. Zhang F, Yang Y, Skrip L, Hu D, Wang Y, Wong C, et al. Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies. Acta Diabetol 2012;49 Suppl 1:S235-S246.
20. Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Adv Exp Med Biol 2014;816:153-181. PMID:
24818723
24. Caini S, Gandini S, Dudas M, Bremer V, Severi E, Gherasim A. Sexually transmitted infections and prostate cancer risk: a systematic review and meta-analysis. Cancer Epidemiol 2014;38:329-338. PMID:
24986642
25. Hrbacek J, Urban M, Hamsikova E, Tachezy R, Heracek J. Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review. Urol Oncol 2013;31:951-965. PMID:
22459691
26. Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate 2013;73:236-241. PMID:
22851253
27. Lin Y, Mao Q, Zheng X, Yang K, Chen H, Zhou C, et al. Human papillomavirus 16 or 18 infection and prostate cancer risk: a meta-analysis. Ir J Med Sci 2011;180:497-503. PMID:
21400096
28. Al Moustafa AE. Involvement of human papillomavirus infections in prostate cancer progression. Med Hypotheses 2008;71:209-211. PMID:
18468811
29. Al-Maghrabi JA. The role of human papillomavirus infection in prostate cancer. Saudi Med J 2007;28:326-333. PMID:
17334454
31. Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, et al. Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study. Cancer Epidemiol Biomarkers Prev 2005;14:2952-2955. PMID:
16365015
33. Ramezani A, Banifazl M, Eslamifar A, Aghakhani A. Association between human papillomavirus infection and risk of prostate cancer. Iran J Pathol 2011;6:3-7.
34. Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003;12:763-768. PMID:
12917208
35. Grover PL, Martin FL. The initiation of breast and prostate cancer. Carcinogenesis 2002;23:1095-1102. PMID:
12117765
38. McNicol PJ, Dodd JG. High prevalence of human papillomavirus in prostate tissues. J Urol 1991;145:850-853. PMID:
1848641
39. Rotola A, Monini P, Di Luca D, Savioli A, Simone R, Secchiero P, et al. Presence and physical state of HPV DNA in prostate and urinary-tract tissues. Int J Cancer 1992;52:359-365. PMID:
1328067
40. Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, et al. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 1992;148:1822-1826. PMID:
1279224
41. Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 1992;52:5991-5996. PMID:
1382850
42. Tu H, Jacobs SC, Mergner WJ, Kyprianou N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 1994;44:726-731. PMID:
7974946
43. Moyret-Lalle C, Marçais C, Jacquemier J, Moles JP, Daver A, Soret JY, et al. ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 1995;64:124-129. PMID:
7542226
44. Terris MK, Peehl DM. Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized. Urology 1997;50:150-156. PMID:
9218040
45. Noda T, Sasagawa T, Dong Y, Fuse H, Namiki M, Inoue M. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 1998;26:165-169. PMID:
9694597
46. Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 1999;59:823-825. PMID:
10029070
47. Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, et al. Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 2004;19:257-261. PMID:
15646830
49. May M, Kalisch R, Hoschke B, Juretzek T, Wagenlehner F, Brookman-Amissah S, et al. Detection of papillomavirus DNA in the prostate: a virus with underestimated clinical relevance? Urologe A 2008;47:846-852 (German). PMID:
18392798
50. Silvestre RV, Leal MF, Demachki S, Nahum MC, Bernardes JG, Rabenhorst SH, et al. Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil. Mem Inst Oswaldo Cruz 2009;104:665-667. PMID:
19722096
51. Aghakhani A, Hamkar R, Parvin M, Ghavami N, Nadri M, Pakfetrat A, et al. The role of human papillomavirus infection in prostate carcinoma. Scand J Infect Dis 2011;43:64-69. PMID:
20662618
53. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558. PMID:
12111919
54. Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, et al. The role of human papillomavirus infection in breast cancer. Med Oncol 2012;29:48-55. PMID:
21318737
55. Effert PJ, Frye RA, Neubauer A, Liu ET, Walther PJ. Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. J Urol 1992;147:192-196. PMID:
1309581
56. Serfling U, Ciancio G, Zhu WY, Leonardi C, Penneys NS. Human papillomavirus and herpes virus DNA are not detected in benign and malignant prostatic tissue using the polymerase chain reaction. J Urol 1992;148:192-194. PMID:
1319507
57. Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD. Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate 1993;22:171-180. PMID:
8384363
58. Saad F, Gu K, Jean-Baptiste J, Gauthier J, MesMasson AM. Absence of human papillomavirus sequences in early stage prostate cancer. Can J Urol 1999;6:834-838. PMID:
11180776
59. Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002;53:263-276. PMID:
12430138
60. Leskinen MJ, Vainionp R, Syrjnen S, Leppilahti M, Marttila T, Kylml T, et al. Herpes simplex virus, cytomegalovirus, and papillomavirus DNA are not found in patients with chronic pelvic pain syndrome undergoing radical prostatectomy for localized prostate cancer. Urology 2003;61:397-401. PMID:
12597955
62. Balis V, Sourvinos G, Soulitzis N, Giannikaki E, Sofras F, Spandidos DA. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers 2007;22:245-251. PMID:
18161654
63. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 2008;68:306-320. PMID:
18163428
64. Masood S, Rhatigan RM, Powell S, Thompson J, Rodenroth N. Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J 1991;84:235-236. PMID:
1703667
65. Dodd JG, Paraskevas M, McNicol PJ. Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol 1993;149:400-402. PMID:
7678873
66. Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate 1996;28:318-324. PMID:
8610059
67. Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, et al. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 1996;28:117-123. PMID:
8604392
68. Anderson M, Handley J, Hopwood L, Murant S, Stower M, Maitland NJ. Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing. J Med Virol 1997;52:8-13. PMID:
9131451
69. Strickler HD, Burk R, Shah K, Viscidi R, Jackson A, Pizza G, et al. A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 1998;82:1118-1125. PMID:
9506358
70. Gazzaz FS, Mosli HA. Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J 2009;30:633-637. PMID:
19417961
73. Chen AC, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D, et al. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res 2011;17:613-617. PMID:
21240663
74. Smelov V, van Moorselaar J, Startsev V, Smelova N, Grigorovich E, Meijer C, et al. No high-risk human papillomavirus infection in prostate cancer tissues. Scand J Infect Dis 2011;43:399-400. PMID:
21250904
75. Tachezy R, Hrbacek J, Heracek J, Salakova M, Smahelova J, Ludvikova V, et al. HPV persistence and its oncogenic role in prostate tumors. J Med Virol 2012;84:1636-1645. PMID:
22930513
76. Michopoulou V, Derdas SP, Symvoulakis E, Mourmouras N, Nomikos A, Delakas D, et al. Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. Tumour Biol 2014;35:12765-12773. PMID:
25213701
80. Chung JI. Prevention of prostate cancer. J Korean Med Assoc 2010;53:135-141 (Korean).
82. La Vecchia C, Bosetti C. Urological cancer: Aspirin and the risk of prostate cancer mortality. Nat Rev Clin Oncol 2012;9:616-617. PMID:
23044777
83. Castellsagué X, Schneider A, Kaufmann AM, Bosch FX. HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol 2009;115:S15-S23. PMID:
19819540
84. Vedham V, Divi RL, Starks VL, Verma M. Multiple infections and cancer: implications in epidemiology. Technol Cancer Res Treat 2014;13:177-194. PMID:
23919392
86. Park S, Bae J, Nam BH, Yoo KY. Aetiology of cancer in Asia. Asian Pac J Cancer Prev 2008;9:371-380. PMID:
18990005
87. Colón-López V, Ortiz AP, Palefsky J. Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J 2010;29:232-240. PMID:
20799510
88. Konya J, Dillner J. Immunity to oncogenic human papillomaviruses. Adv Cancer Res 2001;82:205-238. PMID:
11447764